8-K: Adia Med Repays CEO's $1M Credit Line

Adia Med, Inc. has fully repaid and discharged its $1,000,000 unsecured revolving line of credit provided by its CEO, Larry Powalisz.

Summary

• Adia Med, Inc. (the Company) has fully repaid an unsecured revolving line of credit facility.
• The facility was originally entered into on June 30, 2024, with Larry Powalisz, the Company's Chief Executive Officer, serving as the lender.
• The credit line was increased over time to a total commitment of $1,000,000.
• Interest on the facility was set at 6% per annum.
• The Company made payments totaling $934,970.94 to satisfy the obligation.
• This total payment included $500,000 on October 7, 2026, and $434,970.94 on October 9, 2026.
• The October 9, 2026 payment included $74,658.94 in accrued interest.
• The lender, Larry Powalisz, has acknowledged full repayment of principal and interest as of October 9, 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive development, as it resolves a debt obligation to a related party, reducing financial complexity, though it doesn't represent new growth or revenue.

Positives

• Full repayment of a $1,000,000 unsecured revolving line of credit.
• Elimination of debt obligation to a related party (CEO).
• Confirmation of satisfaction of all amounts owing under the facility.
• Simplification of the Company's financial structure by discharging the credit line.

Negatives

• The total amount paid ($934,970.94) was less than the full $1,000,000 commitment, indicating the full amount was not drawn down.
• Significant portion of the final payment was accrued interest ($74,658.94).

Risks

• Reliance on related party financing in the past, although now repaid.
• The need for a $1,000,000 credit facility suggests potential cash flow or working capital needs.

Future Outlook

The filing does not contain specific forward-looking statements or guidance. The primary focus is on the settlement of a past financial obligation.

Management Comments

• The Lender (Larry Powalisz) has acknowledged that the outstanding principal balance and all accrued interest under the Facility have been paid in full as of October 9, 2026.
• The Facility is satisfied in full, with respect to all amounts owing through that date.

Industry Context

StockSavvy.ai notes that the repayment of debt, especially to related parties like a CEO, can be viewed positively as it cleans up the balance sheet and reduces potential conflicts of interest. However, it does not indicate new business growth or operational improvements.

Related Party Transactions

• Repayment of an unsecured revolving line of credit facility originally provided by Larry Powalisz, the Company's Chief Executive Officer.

Stakeholder Impact

• Shareholders: Positive impact due to the reduction of debt and simplification of the company's financial structure.
• Creditors: Neutral impact, as this repayment does not affect external creditors.
• Management: Positive impact as the CEO's financial exposure to the company is now settled.

Next Steps

• The Company has fully discharged its obligation under the unsecured revolving line of credit.
• The Company will continue its operations without this outstanding debt facility.

Key Dates

Keywords

Credit Line Repayment, Related Party Debt, CEO Financing, Debt Discharge, Financial Obligation, Adia Med